LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4850
0.00 (0.00%)
Oct 22, 2026, 10:33 AM AEDT
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 88.4 million as of October 21, 2026. It is the 28,757th most valuable company in the world and the 645th biggest in Australia. Its market cap has decreased by 4.56% in one year.
Market Cap
88.40M
Enterprise Value
68.74M
Revenue
723.94K
Global Rank
Country Rank
#645 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 88.40M, an increase of 66.86%. That is a compound annual growth rate of 19.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 88.40M | -32.41% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 126.08M |
| Nyrada | 116.37M |
| Recce Pharmaceuticals | 108.55M |
| Island Pharmaceuticals | 100.67M |
| Avecho Biotechnology | 65.68M |
| Prescient Therapeutics | 65.20M |
| Arovella Therapeutics | 61.65M |